Concepedia

Huaigeng Xu

HX

11

Publications

1.6K

Citations

11

H-Index

2018

Active since

Affiliations

Kyoto University(Current)

Central Institute for Experimental Animals

University of California, San Francisco

Takeda (Japan)

Japan Agency for Medical Research and Development

Huaigeng Xu is an author at Kyoto University specializing in medicine, gene editing, and crispr.

ORCID

Top concepts

Publications per year

2018–2022

11

Publications

11

Targeted Disruption of HLA Genes via CRISPR-Cas9 Generates iPSCs with Enhanced Immune Compatibility

Huaigeng Xu, Bo Wang, Miyuki Ono et al. · Cell stem cell · 2019 · 564 citations · Full text

, , +13

Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skipping

Peter Gee, Mandy Siu Yu Lung, Yuya Okuzaki et al. · Nature Communications · 2020 · 349 citations · Full text

Generation of hypoimmunogenic T cells from genetically engineered allogeneic human induced pluripotent stem cells

Bo Wang, Shoichi Iriguchi, Masazumi Waseda et al. · Nature Biomedical Engineering · 2021 · 187 citations

, , +14

CRISPR-Cas3 induces broad and unidirectional genome editing in human cells

Hiroyuki Morisaka, Kazuto Yoshimi, Yuya Okuzaki et al. · Nature Communications · 2019 · 186 citations · Full text

iPSC-Derived Platelets Depleted of HLA Class I Are Inert to Anti-HLA Class I and Natural Killer Cell Immunity

Daisuke Suzuki, Charlotte Flahou, Norihide Yoshikawa et al. · Stem Cell Reports · 2019 · 74 citations · Full text

Rows per page

1–5 of 11